Ticker Scorecard - VNDA Basics Company: Vanda Pharmaceuticals Inc. IPO Date: April 12, 2006 Sector: Healthcare Industry: Biotech Market Cap: $258.34M Activated in VL: True Average Daily Range Avg Daily Range: $0.25 | 2.39% Avg Daily Range (30 D): $0.09 | 2.05% Avg Daily Range (90 D): $0.09 | 1.93% Institutional Daily Volume Avg Daily Volume: .57M Avg Daily Volume (30 D): .58M Avg Daily Volume (90 D): .6M Trade Size Avg Trade Size (Sh.): 144 Avg Trade Size (Sh.) (30 D): 148 Avg Trade Size (Sh.) (90 D): 141 Institutional Trades Total Inst.Trades: 3,113 Avg Inst. Trade: $1.5M Avg Inst. Trade (30 D): $2.21M Avg Inst. Trade (90 D): $1.61M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.57M Avg Closing Trade (30 D): $.87M Avg Closing Trade (90 D): $.79M Avg Closing Volume: 120.76K     News Oct 9, 2024 @ 5:00 PM Schizophrenia Clinical Trial Pipeline Insights Fea... Source: Delveinsight Jun 7, 2024 @ 10:02 AM Vanda (VNDA) Surges 24.2%: Is This an Indication o... Source: Zacks Equity Research May 16, 2024 @ 3:24 PM Vanda (VNDA) Rises on Positive Data From Motion Si... Source: Zacks Equity Research May 2, 2024 @ 10:40 PM Zymeworks Inc. (ZYME) Reports Q1 Loss, Misses Reve... Source: Zacks Equity Research Apr 24, 2024 @ 10:00 PM Vanda Pharmaceuticals (VNDA) Stock Sinks As Market... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.29 $-.09 $-.08 Diluted EPS $-.29 $-.09 $-.08 Revenue $ 190.86M $ 47.65M $ 50.47M Gross Profit $ $ $ Net Income / Loss $ -16.39M $ -5.32M $ -4.52M Operating Income / Loss $ -37.48M $ -11M $ -10.15M Cost of Revenue $ $ $ Net Cash Flow $ -.19M $ -.07M $ .02M PE Ratio